PHS
ERAS icon

PFM Health Sciences’s Erasca ERAS Stock Holding History

PFM Health Sciences’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Buy
+134,088
New +$1.92M 0.21% 88
2025
Q3 		– Sell
-1,072,224
Closed -$1.36M – 78
2025
Q2 		$1.36M Sell
1,072,224
-2,417,335
-69% -$3.24M 0.12% 53
2025
Q1 		$4.78M Sell
3,489,559
-900,868
-21% -$1.55M 0.35% 43
2024
Q4 		$11M Sell
4,390,427
-486,484
-10% -$1.33M 0.68% 42
2024
Q3 		$13.3M Buy
4,876,911
+205,137
+4% +$578K 0.75% 34
2024
Q2 		$11M Buy
4,671,774
+2,136,672
+84% +$4.61M 0.55% 46
2024
Q1 		$5.22M Sell
2,535,102
-40,409
-2% -$80.8K 0.25% 67
2023
Q4 		$5.49M Sell
2,575,511
-1,355,122
-34% -$2.86M 0.33% 51
2023
Q3 		$7.74M Sell
3,930,633
-866,827
-18% -$2.22M 0.36% 59
2023
Q2 		$13.2M Hold
4,797,460
– – 0.51% 53
2023
Q1 		$14.4M Hold
4,797,460
– – 0.64% 53
2022
Q4 		$20.7M Sell
4,797,460
-2,467,521
-34% -$16.7M 0.74% 51
2022
Q3 		$56.7M Buy
7,264,981
+1,383,599
+24% +$11.1M 2.05% 13
2022
Q2 		$32.8M Buy
5,881,382
+1,089,976
+23% +$7.13M 1.25% 36
2022
Q1 		$41.2M Sell
4,791,406
-399,999
-8% -$4.63M 1.54% 28
2021
Q4 		$77M Hold
5,191,405
– – 2.62% 10
2021
Q3 		$98.2M Buy
+5,191,405
New +$107M 2.89% 7

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

PFM Health Sciences's ERAS Position: Q2 2026 in Review

PFM Health Sciences opened a new position in Erasca (ERAS) in Q2 2026: 134,088 shares worth $2.46M. The stake represents 0.21% of the portfolio and ranks #88 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in ERAS as recently as Q2 2025.

PFM Health Sciences first reported a position in ERAS in Q3 2021 and has held it in 17 quarters since. The position peaked at $98.2M in Q3 2021. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • PFM Health Sciences held 134,088 shares of Erasca worth $2.46M as of Q2 2026.
  • Erasca was a new PFM Health Sciences position in Q2 2026.
  • Erasca made up 0.21% of PFM Health Sciences's portfolio in Q2 2026, its #88 holding.
  • PFM Health Sciences first reported a position in Erasca in Q3 2021 and has held it in 17 quarters since.
  • PFM Health Sciences's Erasca position peaked at $98.2M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.